loadpatents
Patent applications and USPTO patent grants for Shankar; Bandarpalle B..The latest application filed is for "silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases".
Patent | Date |
---|---|
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections Grant 9,433,621 - Arasappan , et al. September 6, 2 | 2016-09-06 |
Silyl-containing Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20150057246 - Dwyer; Michael P. ;   et al. | 2015-02-26 |
Substituted Biphenylene Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140377223 - Kozlowski; Joseph A. ;   et al. | 2014-12-25 |
Compounds for the treatment of inflammatory disorders Grant 8,859,529 - Shankar , et al. October 14, 2 | 2014-10-14 |
Compounds for the treatment of inflammatory disorders Grant 8,569,336 - Tong , et al. October 29, 2 | 2013-10-29 |
Compounds for the treatment of inflammatory disorders Grant 8,541,572 - Kozlowski , et al. September 24, 2 | 2013-09-24 |
Compounds for the treatment of inflammatory diseases Grant 8,450,355 - Wong , et al. May 28, 2 | 2013-05-28 |
Compounds For The Treatment Of Inflammatory Disorders App 20120015926 - Tong; Ling ;   et al. | 2012-01-19 |
Compounds For The Treatment Of Inflammatory Disorders App 20120010181 - Kozlowski; Joseph A. ;   et al. | 2012-01-12 |
Compounds For The Treatment Of Inflammatory Disorders App 20110288054 - Shankar; Bandarpalle B. ;   et al. | 2011-11-24 |
Compounds For The Treatment Of Inflammatory Diseases App 20110288077 - Wong; Michael K.C. ;   et al. | 2011-11-24 |
Compounds for the treatment of inflammatory disorders Grant 7,879,890 - Yu , et al. February 1, 2 | 2011-02-01 |
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,868,005 - Rosenblum , et al. January 11, 2 | 2011-01-11 |
Substituted heterocyclic compounds with CXCR3 antagonist activity Grant 7,781,437 - Kim , et al. August 24, 2 | 2010-08-24 |
Compounds for the treatment of inflammatory disorders Grant 7,772,263 - Lavey , et al. August 10, 2 | 2010-08-10 |
Piperazine-piperidines with CXCR3 antagonist activity Grant 7,763,616 - Yu , et al. July 27, 2 | 2010-07-27 |
Cannabinoid receptor ligands Grant 7,750,158 - Shankar , et al. July 6, 2 | 2010-07-06 |
Cannabinoid receptor ligands Grant 7,718,702 - Kozlowski , et al. May 18, 2 | 2010-05-18 |
Compounds for the treatment of inflammatory disorders Grant 7,687,527 - Yu , et al. March 30, 2 | 2010-03-30 |
Compounds for the treatment of inflammatory disorders Grant 7,683,085 - Yu , et al. March 23, 2 | 2010-03-23 |
Compounds for the treatment of inflammatory disorders Grant 7,683,088 - Lavey , et al. March 23, 2 | 2010-03-23 |
Cannabinoid receptor ligands Grant 7,645,774 - Friary , et al. January 12, 2 | 2010-01-12 |
Cannabinoid receptor ligands Grant 7,642,272 - Shankar , et al. January 5, 2 | 2010-01-05 |
Compounds For The Treatment Of Inflammatory Disorders App 20090170875 - Yu; Wensheng ;   et al. | 2009-07-02 |
Compounds For The Treatment Of Inflammatory Disorders App 20090156586 - Lavey; Brian J. ;   et al. | 2009-06-18 |
Compounds For The Treatment Of Inflammatory Disorders App 20090137586 - Yu; Wensheng ;   et al. | 2009-05-28 |
Compounds for the treatment of inflammatory disorders Grant 7,524,842 - Lavey , et al. April 28, 2 | 2009-04-28 |
Cannabinoid receptor ligands Grant 7,507,767 - Kozlowski , et al. March 24, 2 | 2009-03-24 |
Compounds for the treatment of inflammatory disorders Grant 7,504,424 - Yu , et al. March 17, 2 | 2009-03-17 |
Compounds for the treatment of inflammatory disorders Grant 7,488,745 - Yu , et al. February 10, 2 | 2009-02-10 |
Compounds for the treatment of inflammatory disorders Grant 7,482,370 - Yu , et al. January 27, 2 | 2009-01-27 |
Compounds for the treatment of inflammatory disorders App 20070265299 - Lavey; Brian J. ;   et al. | 2007-11-15 |
Compounds for the treatment of inflammatory disorders App 20070219218 - Yu; Wensheng ;   et al. | 2007-09-20 |
Compounds for the treatment of inflammatory disorders App 20070197564 - Lavey; Brian J. ;   et al. | 2007-08-23 |
Cannabinoid receptor ligands Grant 7,253,189 - Tong , et al. August 7, 2 | 2007-08-07 |
Cannabinoid receptor agonists Grant 7,217,732 - Kozlowski , et al. May 15, 2 | 2007-05-15 |
Substituted heterocyclic compounds with CXCR3 antagonist activity App 20070082913 - Kim; Seong Heon ;   et al. | 2007-04-12 |
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20070054919 - Rosenblum; Stuart B. ;   et al. | 2007-03-08 |
Piperazine-piperidines with CXCR3 antagonist activity App 20060276457 - Yu; Wensheng ;   et al. | 2006-12-07 |
Compounds for the treatment of inflammatory disorders App 20060276506 - Yu; Wensheng ;   et al. | 2006-12-07 |
Compounds for the treatment of inflammatory disorders App 20060205797 - Yu; Wensheng ;   et al. | 2006-09-14 |
Cannabinoid receptor ligands Grant 7,071,213 - Friary , et al. July 4, 2 | 2006-07-04 |
Cannabinoid receptor ligands Grant 7,067,539 - Kozlowski , et al. June 27, 2 | 2006-06-27 |
Cannabinoid receptor ligands App 20060100228 - Shankar; Bandarpalle B. ;   et al. | 2006-05-11 |
Cannabinoid receptor ligands App 20060009528 - Kozlowski; Joseph A. ;   et al. | 2006-01-12 |
Cannabinoid receptor ligands App 20050282861 - Friary, Richard J. ;   et al. | 2005-12-22 |
Cannabinoid receptor ligands App 20040186148 - Shankar, Bandarpalle B. ;   et al. | 2004-09-23 |
Cannabinoid receptor ligands App 20040132804 - Tong, Ling ;   et al. | 2004-07-08 |
Cannabinoid receptor agonists App 20040044051 - Kozlowski, Joseph A. ;   et al. | 2004-03-04 |
Cannabinoid receptor ligands App 20040010013 - Friary, Richard J. ;   et al. | 2004-01-15 |
Cannabinoid receptor ligands App 20030232859 - Kozlowski, Joseph A. ;   et al. | 2003-12-18 |
Cannabinoid receptor ligands App 20030096844 - Kozlowski, Joseph A. ;   et al. | 2003-05-22 |
Process for preparing 1-(4-fluorophenyl)-3(R)-(3(S)-hydroxy-3-([phenyl or 4-fluorophenyl])-propyl)-4(S)-(4-hydroxyphenyl)-2-azetidinone Grant 5,856,473 - Shankar January 5, 1 | 1999-01-05 |
Substituted oximes, hydrazones and olefins as neurokinin antagonists Grant 5,840,725 - Reichard , et al. November 24, 1 | 1998-11-24 |
Substituted oximes, hydrazones and olefins as neurokinin antagonists Grant 5,696,267 - Reichard , et al. December 9, 1 | 1997-12-09 |
Substituted oximes, hydrazones and olefins useful as neurokinin antagonists Grant 5,688,960 - Shankar November 18, 1 | 1997-11-18 |
Substituted azetidinone compounds useful as hypocholesterolemic agents Grant 5,688,990 - Shankar November 18, 1 | 1997-11-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.